Harmony Biosciences Holdings (HRMY) Income from Continuing Operations (2019 - 2026)
Harmony Biosciences Holdings' Income from Continuing Operations was $75.43 million in Q2 2026, up 89.6% from $39.78 million a year earlier and up 132.2% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) Income from Continuing Operations (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Harmony Biosciences Holdings' Income from Continuing Operations was $181.27 million through Jun 30, 2026, up 0.2% year-over-year; for FY2025, it was $158.69 million, up 9.1% from FY2024.
- In earlier years, Income from Continuing Operations was $145.49 million in FY2024 (+12.9%), $128.85 million in FY2023 (-29.0%), $181.47 million in FY2022 (+424.5%) and $34.6 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Income from Continuing Operations since Q3 2022.
- Compared with a year earlier, Income from Continuing Operations was higher in six of the last eight quarters, with growth averaging 48.1%.
- The best year-over-year quarter for Income from Continuing Operations over five years was Q2 2025 (growth of 243.2%); the worst was Q2 2024 (a decline of 66.2%).
- Per Business Quant data, HRMY's Income from Continuing Operations in the three quarters before Q2 2026 was $32.49 million (Q1 2026), $22.49 million (Q4 2025) and $50.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -474.81 Mn | 198.08 Mn | 75.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.43 Mn |
| Mar 31, 2026 | 32.49 Mn |
| Dec 31, 2025 | 22.49 Mn |
| Sep 30, 2025 | 50.87 Mn |
| Jun 30, 2025 | 39.78 Mn |
| Mar 31, 2025 | 45.56 Mn |
| Dec 31, 2024 | 49.48 Mn |
| Sep 30, 2024 | 46.09 Mn |
| Jun 30, 2024 | 11.59 Mn |
| Mar 31, 2024 | 38.33 Mn |
| Dec 31, 2023 | 26.61 Mn |
| Sep 30, 2023 | 38.46 Mn |
| Jun 30, 2023 | 34.30 Mn |
| Mar 31, 2023 | 29.49 Mn |
| Dec 31, 2022 | 48.51 Mn |
| Sep 30, 2022 | 87.94 Mn |
| Jun 30, 2022 | 23.53 Mn |
| Mar 31, 2022 | 21.49 Mn |
| Dec 31, 2021 | 22.71 Mn |
| Sep 30, 2021 | -9.62 Mn |
API Access
Harmony Biosciences Holdings Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();